Skip to content
Review

FGF23 - A hormone produced by bone and has many faces.

Aug 2026 · Reviews in Endocrine & Metabolic Disorders · 0 citations · 116 references
Medicine

TL;DR

A review of recent findings regarding FGF23 focuses on its classical role as a hormone and its broader effects as a humoral factor on other organs, focusing on the exact mechanisms underlying these pleiotropic actions.

View source

Similar papers

Review Open access Aug 2026

Defining the potential role of the mineralocorticoid receptor in musculoskeletal health and bone crosstalk with other tissues

Excessive mineralocorticoid receptor (MR) activation in the heart and vasculature leads to pathological effects such as extracellular matrix accumulation, oxidative stress, and sustained inflammation. While MR’s role in cardiovascular and renal systems is well understood, MR signaling has also been implicated as a key...

Husam Bensreti, Joseph C. Shaver, Christopher L. Yearwood et al. · 0 citations
Open access Sep 2026

Targeting FGF23 to Ameliorate Anemia in Chronic Kidney Disease

The progression of chronic kidney disease (CKD) entails the development of complications, such as anemia and disturbances in mineral homeostasis, among others, and both of them have been shown to be closely related. In fact, high phosphorus (P) and excessive production of fibroblast growth factor 23 (FGF23) are hallmar...

K. Valdés-Díaz, R. García-Sáez, Casimiro Valle et al. · 0 citations
Open access Oct 2026

FGF-23 is associated with increased risk of abdominal aortic calcification

Fibroblast growth factor 23 (FGF23) is involved in the regulation of phosphate metabolism and has been linked to vascular calcification. However, the genetic association between FGF23 and abdominal aortic calcification (AAC) remains unclear. We conducted a bidirectional two-sample Mendelian randomization (MR) study to...

Lei Song, Juan Chen, Cheng Xue et al. · 0 citations
Review Open access Aug 2026

Advances in FGF/FGFR Signaling: Implications for Disease and Therapy

An overview of FGF/FGFR signaling is provided and its cellular and physiological functions are summarized and the relationship between aberrant (including hyperactivated or inactivated) FGF/FGFR signaling and diverse diseases is explored.

Miao-Yu Song, Xi Liu, Yang Xiao et al. · 0 citations
Review Oct 2026

New insights into the pathogenesis of osteoporosis and the translational approach to personalized therapy.

Osteoporosis is increasingly recognized as a heterogeneous syndrome rather than a single disease, driven by diverse pathophysiological mechanisms. Subtypes-including postmenopausal estrogen deficiency, age-related bone loss, anorexia nervosa, and GLP-1 receptor agonist-associated weight loss-exhibit distinct bone turno...

Bo-Lun Li, Lin-Yi Liu, E. Luo et al. · 0 citations
Review Open access Sep 2026

Role of Local Growth Plate Mechanisms and Systemic Endocrine Signals in X-Linked Hypophosphatemia (XLH) Impaired Linear Growth

Background/Objectives: X-linked hypophosphatemia (XLH), the most frequent heritable cause of hypophosphatemic rickets, is characterized by impaired linear growth and skeletal deformities, that can lead to disproportionate short stature. Linear growth depends on the coordinated regulation of systemic endocrine signals a...

Michela Ferrarese, V. Camozzi, L. Guazzarotti · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.